Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.

Autor:	Rebelatto, Marlon C.1 Marlon.rebelatto@medimmune.com, Midha, Anita2, Mistry, Amita3, Sabalos, Constantine3, Schechter, Nicole3, Xia Li1, Xiaoping Jin1, Steele, Keith E.1, Robbins, Paul B.1, Blake-Haskins, John A.1, Walker, Jill4
Zdroj:	Diagnostic Pathology. 10/8/2016, Vol. 11, p1-14. 14p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu